Trial Information

Summary: Post-Herpetic Neuralgia or PHN.

Approximately 1 in 10 adults get shingles during their lifetime, and it is even more common in those over 50 years of age. Shingles is caused by the chicken pox virus, herpes zoster, which can remain inactive for many years after the initial infection. Shingles occur when the virus reactivates within nerve cells, resulting in pain and skin rash.

Approximately 20% of people who have ahd shingles continue to live with significant pain for more than 3 months after their rash has healed. This condition is called post-herpetic neuralgia or PHN.

What is the purpose of the PHN 1005 Clinical Research Study?
This study will enroll approximately 87 to 129 people in the U.S. to help researchers find out:
Whether or not an investigational drug can relieve the pain of PHN
How different doses of the investigational drug compare to placebo
The safety and effectiveness of the investigational drug
How participants bodies absorb, distribute, use and get rid of the investigational drug.

The study needs people with PHN who:
Have pain present for more than 3 months after healing of the shingles rash
Are prepared to be involved over a period of approximately 17 to 20 weeks
Additional requirements would be detailed by the study doctor during an initial assessment

If you would like to learn more about participating in this study, please send an e-mail message using the form below.